FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903204073> ?p ?o ?g. }

• W2903204073 abstract "Efficacy and safety of sorafenib in patients with advanced renal cancer were evaluated. Seventy-four patients with advanced renal cancer treated with sorafenib + interferon from January 2010 to August 2013 were included as the observation group. Another 53 renal cancer patients treated with interferon alone were included in the control group. Clinical data of those patients were retrospectively analyzed. Treatment plan: initial dose was 400 mg, twice a day. Additionally, patients in the interferon group were treated with another 300 MU every other day. Efficacy was evaluated according to RECIST criteria, and progression-free survival (PFS), overall survival (OS), and incidence of adverse reactions were recorded. In the observation group, a median OS was 15.3 months (range, 9-60 months), and a median PFS was 8.2 months (range, 2-36 months). There were 4 cases of complete remission (CR) (5.41%), 16 cases of partial remission (PR) (21.62%), 42 cases of stable disease (SD) (56.76%), 12 cases of disease progression (16.22%), and disease control rate (DCR) was 83.78% (62 cases). In the control group, median OS time was 12.5 months (range, 8-60 months), and the median PFS time was 9.3 months (range, 2-40 months). There were 2 cases of CR (3.77%), 11 cases of PR (20.75%), 20 cases of SD (37.74%), 20 cases of disease progression (37.74%), and DCR was 62.26% (33 cases). Disease control rate in the observation group was significantly higher than that in the control group (P<0.05). Main adverse events in the groups were skin reaction, fever, diarrhea, fatigue, rash, loss of appetite, hypertension, hair loss and liver function abnormality. Sorafenib-based targeted therapy for the treatment of advanced renal cancer has a higher rate of disease control, and the adverse reactions are controllable and tolerable." @default.
• W2903204073 created "2018-12-11" @default.
• W2903204073 creator A5015211419 @default.
• W2903204073 creator A5031810848 @default.
• W2903204073 creator A5032331494 @default.
• W2903204073 creator A5041925408 @default.
• W2903204073 creator A5056113115 @default.
• W2903204073 creator A5078361927 @default.
• W2903204073 creator A5080501181 @default.
• W2903204073 creator A5087982978 @default.
• W2903204073 date "2018-11-28" @default.
• W2903204073 modified "2023-09-26" @default.
• W2903204073 title "Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer" @default.
• W2903204073 cites W1717153315 @default.
• W2903204073 cites W1757407923 @default.
• W2903204073 cites W1860591201 @default.
• W2903204073 cites W1972492013 @default.
• W2903204073 cites W1980492568 @default.
• W2903204073 cites W2016321427 @default.
• W2903204073 cites W2018163822 @default.
• W2903204073 cites W2031941707 @default.
• W2903204073 cites W2100173894 @default.
• W2903204073 cites W2114959070 @default.
• W2903204073 cites W2129350547 @default.
• W2903204073 cites W2164317031 @default.
• W2903204073 cites W2171902233 @default.
• W2903204073 cites W2174734259 @default.
• W2903204073 cites W2210453860 @default.
• W2903204073 cites W2221837786 @default.
• W2903204073 cites W2272882882 @default.
• W2903204073 cites W2324532698 @default.
• W2903204073 cites W2480386446 @default.
• W2903204073 cites W2558408743 @default.
• W2903204073 cites W2767623795 @default.
• W2903204073 doi "https://doi.org/10.3892/ol.2018.9776" @default.
• W2903204073 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6341818" @default.
• W2903204073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30675211" @default.
• W2903204073 hasPublicationYear "2018" @default.
• W2903204073 type Work @default.
• W2903204073 sameAs 2903204073 @default.
• W2903204073 citedByCount "1" @default.
• W2903204073 countsByYear W29032040732023 @default.
• W2903204073 crossrefType "journal-article" @default.
• W2903204073 hasAuthorship W2903204073A5015211419 @default.
• W2903204073 hasAuthorship W2903204073A5031810848 @default.
• W2903204073 hasAuthorship W2903204073A5032331494 @default.
• W2903204073 hasAuthorship W2903204073A5041925408 @default.
• W2903204073 hasAuthorship W2903204073A5056113115 @default.
• W2903204073 hasAuthorship W2903204073A5078361927 @default.
• W2903204073 hasAuthorship W2903204073A5080501181 @default.
• W2903204073 hasAuthorship W2903204073A5087982978 @default.
• W2903204073 hasBestOaLocation W29032040731 @default.
• W2903204073 hasConcept C120665830 @default.
• W2903204073 hasConcept C121332964 @default.
• W2903204073 hasConcept C121608353 @default.
• W2903204073 hasConcept C126322002 @default.
• W2903204073 hasConcept C141071460 @default.
• W2903204073 hasConcept C197934379 @default.
• W2903204073 hasConcept C2777472916 @default.
• W2903204073 hasConcept C2778019345 @default.
• W2903204073 hasConcept C2778695046 @default.
• W2903204073 hasConcept C2778822529 @default.
• W2903204073 hasConcept C2779134260 @default.
• W2903204073 hasConcept C61511704 @default.
• W2903204073 hasConcept C71924100 @default.
• W2903204073 hasConcept C90924648 @default.
• W2903204073 hasConceptScore W2903204073C120665830 @default.
• W2903204073 hasConceptScore W2903204073C121332964 @default.
• W2903204073 hasConceptScore W2903204073C121608353 @default.
• W2903204073 hasConceptScore W2903204073C126322002 @default.
• W2903204073 hasConceptScore W2903204073C141071460 @default.
• W2903204073 hasConceptScore W2903204073C197934379 @default.
• W2903204073 hasConceptScore W2903204073C2777472916 @default.
• W2903204073 hasConceptScore W2903204073C2778019345 @default.
• W2903204073 hasConceptScore W2903204073C2778695046 @default.
• W2903204073 hasConceptScore W2903204073C2778822529 @default.
• W2903204073 hasConceptScore W2903204073C2779134260 @default.
• W2903204073 hasConceptScore W2903204073C61511704 @default.
• W2903204073 hasConceptScore W2903204073C71924100 @default.
• W2903204073 hasConceptScore W2903204073C90924648 @default.
• W2903204073 hasLocation W29032040731 @default.
• W2903204073 hasLocation W29032040732 @default.
• W2903204073 hasLocation W29032040733 @default.
• W2903204073 hasLocation W29032040734 @default.
• W2903204073 hasOpenAccess W2903204073 @default.
• W2903204073 hasPrimaryLocation W29032040731 @default.
• W2903204073 hasRelatedWork W2048324721 @default.
• W2903204073 hasRelatedWork W2108827015 @default.
• W2903204073 hasRelatedWork W2770832082 @default.
• W2903204073 hasRelatedWork W2792486919 @default.
• W2903204073 hasRelatedWork W2885058918 @default.
• W2903204073 hasRelatedWork W2889897913 @default.
• W2903204073 hasRelatedWork W2914095913 @default.
• W2903204073 hasRelatedWork W2965379778 @default.
• W2903204073 hasRelatedWork W3111568800 @default.
• W2903204073 hasRelatedWork W3217677266 @default.
• W2903204073 isParatext "false" @default.
• W2903204073 isRetracted "false" @default.
• W2903204073 magId "2903204073" @default.
• W2903204073 workType "article" @default.